To top

Areas of Expertise

Dr Kapil Bhargava performs a range of treatments including:

Some of the conditions he commonly treats are:

Personal Biography

Dr Kapil Bhargava trained in Dermatology at St John’s Institute of Dermatology in all aspects of general and specialist Dermatology and was awarded CCT (Dermatology) by the General Medical Council.

He is on the GMC Specialist Register for Dermatology and has completed a prestigious Joint Royal Colleges of Physicians Training Board (JRCPTB) approved post-CCT Fellowship in Mohs and Advanced Dermatologic Surgery. Additionally, he has taken other training in both Europe and the US and continues to update his knowledge and skills to remain at the forefront of his speciality.

Dr Kapil Bhargava has received a manifold of awards for his work in the field including:

  • Michael Hornstein Memorial Scholarship from European Academy of Dermatology and Venereology (EADV)
  • British Skin Foundation Grant Award
  • British Association of Dermatologists (BAD)/Dowling Club Travel Fellowship
  • University College London MBBS Merit Award
  • Amulree Bursary
  • British Medical and Dental Students Trust Elective Award

Research

Dr Kapil Bhargava has authored scientific papers in peer-reviewed journals and contributed to book chapters such as the hair and scalp chapter in the renowned ABC in Dermatology series.

Key Publications

  • Bhargava K and Fenton D (2019). Hair and Scalp. In R. Morris-Jones (Ed.), ABC of Dermatology. 7th Ed. London: BMJ Books
  • Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.Tziotzios C, Petridis C, Dand N, Ainali C, Saklatvala JR, Pullabhatla V, Onoufriadis A, Pramanik R, Baudry D, Lee SH, Wood K, Liu L, Seegobin S, Michelotti GA, Lwin SM, Christou EAA, Curtis CJ, de Rinaldis E, Saxena A, Holmes S, Harries M, Palamaras I, Cunningham F, Parkins G, Kaur M, Farrant P, McDonagh A, Messenger A, Jones J, Jolliffe V, Ali I, Ardern-Jones M, Mitchell C, Burrows N, Atkar R, Banfield C, Alexandroff A, Champagne C, Cooper HL, Vañó-Galván S, Molina-Ruiz AM, Perez NO, Patel GK, Macbeth A, Page M, Bryden A, Mowbray M, Wahie S, Armstrong K, Cooke N, Goodfield M, Man I, de Berker D, Dunnill G, Takwale A, Rao A, Siah TW, Sinclair R, Wade MS, Dlova NC, Setterfield J, Lewis F, Bhargava K, Kirkpatrick N, Estivill X, Stefanato CM, Flohr C, Spector T, Watt FM, Smith CH, Barker JN, Fenton DA, Simpson MA, McGrath JA. Nature Commun. 2019 Mar 8;10(1):1150.
  • Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies. Tziotzios C, Brier T, Lee JYW, Saito R, Hsu CK, Bhargava K, Stefanato CM, Fenton DA, McGrath JA. J Am Acad Dermatol. 2018 Nov;79(5):807-818.
  • Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis. Tziotzios C, Lee JYW, Brier T, Saito R, Hsu CK, Bhargava K, Stefanato CM, Fenton DA, McGrath JA. J Am Acad Dermatol. 2018 Nov;79(5):789-804.
  • Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia. Tziotzios C, Ainali C, Holmes S, Cunningham F, Lwin SM, Palamaras I, Bhargava K, Rymer J, Stefanato CM, Kirkpatrick N, Vano-Galvan S, Petridis C, Fenton DA, Simpson MA, Onoufriadis A, McGrath JA. J Invest Dermatol. 2017 Nov;137(11):2440-2443
  • Frontal fibrosing alopecia: there is no statistically significant association with leave-on facial skin care products and sunscreens. Seegobin SD, Tziotzios C, Stefanato CM, Bhargava K, Fenton DA, McGrath JA. Br J Dermatol. 2016 Dec;175(6):1407-1408

Get to know Dr Kapil Bhargava..

Dr Bhargava enjoys re-exploring the world through the eyes of his kids, scuba diving, travel, amazing food and always learning.

  • What is your approach to patients who attend with hair loss?

    I don’t treat hair loss; rather I treat a person with hair loss. It is essential to assess hair loss in the context of the whole person and acknowledge the psychological impact that it may cause. Hair and scalp issues often reflect medical health, lifestyle, nutritional and psychological factors and these are evaluated. My aim is to help patients understand their condition, and their treatment choices, to ensure they choose options that are right for them.

  • How important is personalised care in the management of skin cancer?

    An optimal treatment plan is formed by integrating an accurate diagnosis with an understanding the personal characteristics of a patient and coupling these with the best scientific evidence. The microscopic characteristics of an individual’s tumour, a person’s unique anatomy, factors affecting their general health and their preference for a particular treatment are all factors that need to be considered. This approach enables me to deliver an outcome best suited to an individual’s needs, rather than relying on a protocol driven approach.

  • What should patients expect from a consultation?

    I want to patients to discuss their concerns and encourage them to ask all their questions. I want them to feel they understand their condition and their treatment options and know that they have time to consider these. In addition to addressing their immediate concerns, it is also important to focus on prevention of future problems and maximise skin health.